Blood test could replace risky biopsies for heart transplant patients
NCT ID NCT02672683
Summary
This study tested a new blood test to detect rejection in heart transplant patients. It aimed to see if measuring four specific molecules in the blood could accurately identify rejection, potentially replacing the need for frequent, invasive heart biopsies. The study involved 461 patients across multiple hospitals to confirm the test's reliability.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
PARCC/ INSERM U970, Team 4, Xavier Jouven, Cardiovascular epidemiology and sudden death, Georges Pompidou European Hospital,
Paris, 75015, France
Conditions
Explore the condition pages connected to this study.